Yüklüyor......

In silico comparison of pharmacokinetic properties of three extended half-life factor IX concentrates

PURPOSE: Pharmacokinetic (PK) differences between the extended half-life (EHL) factor IX (FIX) concentrates for hemophilia B exist, which may influence hemostatic efficacy of replacement therapy in patients. Therefore, we aimed to evaluate the PK properties of three EHL-FIX concentrates and compare...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur J Clin Pharmacol
Asıl Yazarlar: Preijers, Tim, Bukkems, Laura, van Spengler, Max, Leebeek, Frank, Cnossen, Marjon, Mathôt, Ron
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2021
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8275546/
https://ncbi.nlm.nih.gov/pubmed/33624121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-021-03111-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!